You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)

Citation Tools

Article menu

Download PDFPDF

XML
Emergency medicine
Protocol
Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Strauss DH, Santhanam DR, McLean SA, et al
Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)
BMJ Open 2019;9:e025002. doi: 10.1136/bmjopen-2018-025002